PPH: Buy The Pullback In This Big Pharma ETF For Long-Term Total Returns

VanEck Pharmaceutical ETF is a popular option for investors looking for exposure to leading pharmaceutical companies. The ETF's top holdings include Eli Lilly, Novo Nordisk, and Johnson & Johnson. The fund has been in an uptrend since late last year and is currently trading at a level that presents a buying opportunity.

Weekly Report: what happened at PPH last week (0415-0419)?

JNJ Beats Q1 Earnings Estimates, Misses on Sales: ETFs in Focus

Weekly Report: what happened at PPH last week (0408-0412)?

Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?

Weekly Report: what happened at PPH last week (0401-0405)?

VanEck Pharmaceutical ETF declares quarterly distribution of $0.5328

VanEck Vectors Pharmaceutical ETF declares quarterly distribution of $0.5328

Weekly Report: what happened at PPH last week (0325-0329)?

Cons Disc distribution & retail has the highest dispersion among S&P groups - MS

Consumer discretionary distribution & retail has the highest dispersion among S&P groups. Morgan Stanley analysts monitored the dispersion metrics of the S&p 500 and its sectors and subsectors. Dispersion measures the range of returns for a group, Morgan Stanley says. High dispersion present in auto and household, lower in utilities and energy.

Weekly Report: what happened at PPH last week (0318-0322)?

Thursday's ETF with Unusual Volume: PPH

Weekly Report: what happened at PPH last week (0311-0315)?

Weekly Report: what happened at PPH last week (0304-0308)?

Why Biotech Stocks May Be Ready For A Recovery

Biotech stocks have struggled in recent quarters as high interest rates take a toll on the capital-intensive sector. Jared Ablass, Vice President, Portfolio Research at TD Asset Management, speaks with MoneyTalk's Greg Bonnell about how the biotech sector could benefit once rates start to come down. Why beaten down Biotech stocks could be ready for a recovery.

Novo Nordisk's Game-Changer: FDA Approves Weight Loss Sensation Wegovy For Heart Health, Potential Insurance Coverage

Novo Nordisk A/S’s Wegovy gets approval for expanded use in the U.S. The Danish drugmaker's drug is a weight management therapy for obesity and cardiovascular disease. The FDA approved the drug for a significant reduction in major adverse cardiovascular events. Shares of Novo Nordisk were down 1.9% Friday.

Should You Invest in the VanEck Pharmaceutical ETF (PPH)?

The Top 3 ETFs to Buy in March 2024

Top ETFs to buy offer a smart solution for those looking to diversify their portfolios without the hassle. The Global X Artificial Intelligence & Technology ETF (AIQ) has surged by 45% over the past year. The VanEck Pharmaceutical ETF (PPH) is a fund dedicated to the booming AI industry. Pacer US Cash Cows 100 ETF (COWZ) has a unique focus on free cash flows.

Weekly Report: what happened at PPH last week (0226-0301)?

11 'Granolas' Stocks Outperform Magnificent 7 With Lower Volatility, Higher Yields

A small group of European stocks has quietly outperformed most of the world. Goldman Sachs dubbed the group "Granolas" and it accounted for 50% of gains of the Stoxx Europe 600 Index for the past year. Granolas refers to a group of 11 European stocks operating in the healthcare and pharmaceutical sector. The group also includes luxury, consumer staples and software technology companies.